Inhibition of the NF-κB pathway and release of pro-inflammatory cytokines by miR-497 in a DSS (dextran sulfate sodium)-induced IBD mouse model and in RAW264.7 cells led to inhibition of inflammation [55]. This evidence concerns the gene NFKB1 and inflammatory bowel disease.